The estimation of efficacy of fluconazole treatment in patients with chronic sinusitis;Ocena skuteczności leczenia flukonazolem chorych na przewlekłe zapalenie zatok przynosowych

Mikologia Lekarska

Volumn 11, Issue 4, 2004, Pages 297-301

  Hofman, Teresa ^a   Skrobisz, Wanda ^a   Hofman, Anna Maria ^a  

^a Centrum Alergologii   (Poland)

Author keywords

Candida; Chronic sinusitis; Fluconazole; Moulds

Indexed keywords

FLUCONAZOLE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASTHMA; ATOPIC DERMATITIS; CANDIDA ALBICANS; CHRONIC SINUSITIS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FUNGUS CULTURE; FUSARIUM MONILIFORME; HUMAN; HYPERTENSION; IMMUNOGLOBULIN BLOOD LEVEL; LIVER FUNCTION; NOSE SECRETION; PENICILLIUM; PENICILLIUM NOTATUM; POLLEN ALLERGY; PRICK TEST; SIDE EFFECT; TREATMENT OUTCOME;

ALTERNARIA; ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; CANDIDA; CANDIDA ALBICANS; FUNGI; FUSARIUM; GIBBERELLA FUJIKUROI; NASO; PENICILLIUM; PENICILLIUM CHRYSOGENUM;

EID: 11244281676     PISSN: 1232986X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. McCaig L.F., Hughes J.M.: Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA, 1995, 273, 214.
2. Gonzales R., Bartlett J.G., Besser R.F., Cooper R.J., Hickner J.M., Hoffman J.R., Sande M.A.: Principles of appropriate antibiotic use for treatment of acute respiratory infections in adults: background, specific aims, and methods. Ann. Intern. Med., 2001, 134, 479.
3. Pawlik B., Macura A.B.: Diagnostyka laboratoryjna w mikologii. [w:] Zarys mikologii lekarskiej. red. E. Baran. Volumed, Wrocław, 1998, 541-572.
4. Kurnatowski G.: Grzybice dróg oddechowych. [w:] Zarys mikologii lekarskiej. red. E. Baran. Volumed, Wroctaw, 1998, 379-391.
5. Pierard G.E.: Inné spojrzenie na leki przeciwgrzybicze: nowoczesne techniki pod mikroskopem. Przegl. Mikol., 2001, 5, 4.
6. Kaczmarek J., Bocheṅska-Marciniak M.: Grzyby i ich udział w chorobach alergicznych. Terapia, 2002, 4, 1, 47.
7. Lintu P., Savolainen J., Kalimo K., Kortekaugas-Savolainen O., Nermes M., Terho E.O.: Cross-reacting IgE and IgG antibodies to Pityrosporium ovale mannan and other yeasts in atopic dermatitis. Allergy, 1999, 54, 1067.
8. Nguyen T.H., Fleet G.H., Rogers P.L.: Composition of the cell walls of several yeasts species. Appl. Microbiol. Biotechnol., 1998, 50, 2, 206.
9. Nowicki R., Bykowska B.: Zmiany w epidemiologii powierzchownych infekcji grzybiczych w rejonie Gdańska. Przegl. Mikol., 2001, 5, 14.
10. Gliṅski W.: Zakażenia grzybicze skóry: znaczenie w chorobach alergicznych. Alergia, 2001, 3, 21.
11. War P.A.B., Gibson P.G.: Allergic bronchopulmonary aspergillosis: New concepts of pathogenesis and treatment. Respirology, 2001, 6, 1.
12. Zawisza E.: Grzyby a choroby alergiczne. Nowa Medycyna, 2001, 109, 11.
13. Kumatowska A.: Biologia i ekologia grzybów chorobotwó rczych. [w:] Zarys mikologii lekarskiej. red. E. Baran. Volumed, Wrocław, 1998, 21.
14. Mungan D., Bavbek S., Peksari V., Celik G., Gügey, Misirligil Z.: Trichophyton sensitivity in allergic and nonallergic asthma. Allergy, 2001, 56, 558.
15. Lipiec A. : Grzyby w etiologii chorób alergicznych. Alergologia Wspȯłczesna, 2002, 1, 10.
16. Brown W.D.: Mould allergy affecting the ears, nose and throat. Otolaryngol. Clin. North Am., 1971, 4, 3.
17. Means-Markwell M., Surges T., DeKeratry D., O'Neil K., Mascola J., Fleisher T., Lucey D.: Brief report: Eosinophilia with aberrant T cells and elevated serum levels of interleukin-2 and interleukin-15 (Article). J. Med., 2000, 288, 1185.
18. Akiyama K., Shida T., Yasueda H., Mita H., Yanagihara Y., Hasegawa M., Maeda Y., Yamamoto T., Takesako K., Yamaguchi H.: Allergenicity of acid protease secreted by Candida albicans. Allergy, 1996, 51, 887.
19. Kang-Rotondo C.H., Miller C.C., Morrison A.R., Pentland A.P.: Enhanced keratinocyte prostaglandin synthesis after UV injury is due to increased phospholipase activity. Am. J. Physiol., 1993, 264, C396.
20. Prakash A., Benfield P.: Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermacological macological disorders. Drug, 1998, 55, 145.
21. Jensen-Jarolim E., Poulsen L.K., With H., Kieffer M., Ottevanger V., Skov P.S.: Atopic dermatitis of the face, calp and neck: type I reaction to the yeats Pityrosporium ovate? J. Allergy Clin. Immunol., 1992, 89, 44.
22. Lintu P., Savolainen J., Kortekangas-Savolainen O., Kalimo K.: Systemic ketokonazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeats. Allergy, 2001, 56, 512.
23. Akiyama K., Shida T., Yasued h., Yamamoto T., Yamaguchi H.: Atopic asthma caused by Candida albicans acid protease: case reports. Allergy, 1994, 49, 778.
24. Shale D.J., Faux J.A., Lane D.J.: Trial of ketokonazol in non-invasive pulmonary aspergillosis. Thorax, 1987, 42, 26.
25. Kaben U.: Fungal infections. Chirurg, 1998, 69, 5, 530.
26. Anaissie E.J., Kontoyiannis D.P., Huls C., Vartivarian S.E., Karl C., Prince R.A., Bosso J., Bodey G.P.: Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections. J. Infect. Dis., 1995, 172, 599.
27. Marquina D., Santos A., Peinado J.M.: Biology of killer yeasts. Arch. Microbiol., 2001, 177, 29.